Carbohydrate polymer-based nanoparticles in curcumin delivery for cancer therapy

Area of Science:

• Natural product chemistry
• Nanotechnology
• Oncology

Background:

• Natural products, like curcumin, have a long history in cancer treatment due to their safety and multifunctionality.
• Curcumin exhibits anticancer properties against various tumors but faces challenges with poor pharmacokinetics, limiting its in vivo and clinical efficacy.
• Nanoparticle-based drug delivery systems are being explored to improve curcumin's therapeutic potential.

Purpose of the Study:

• To evaluate carbohydrate polymer-based nanoparticles as a delivery system for curcumin in cancer treatment.
• To address curcumin's limitations, including low solubility, poor bioavailability, and rapid degradation.
• To enhance curcumin's stability, controlled release, and targeted delivery to cancer cells.

Main Methods:

• Utilized carbohydrate polymers (chitosan, hyaluronic acid, alginate) to create biodegradable and biocompatible nanoparticles.
• Functionalized nanoparticles with targeting ligands for selective tumor cell distribution.
• Investigated the encapsulation of curcumin within nanoparticles to improve stability and control release.
• Explored the potential for co-encapsulation of curcumin with other agents for synergistic therapy.

Main Results:

• Carbohydrate polymer nanoparticles effectively encapsulate curcumin, enhancing its stability and bioavailability.
• Targeted delivery via functionalized nanoparticles improves accumulation in tumor tissues and reduces off-target effects.
• Nanoparticle formulation increases curcumin uptake by cancer cells, leading to enhanced cytotoxicity.
• The platform allows for controlled release of curcumin and potential for combination therapies.

Conclusions:

• Carbohydrate polymer-based nanoparticles represent a revolutionary, functional, and safe platform for curcumin delivery in cancer therapy.
• This approach significantly enhances curcumin's therapeutic effectiveness by overcoming pharmacokinetic limitations.
• The tunable and biocompatible nature of these nanoparticles holds great promise for improved cancer treatment strategies.